Correct Answer: A. Hypoxia causing vasodilation
At high altitude (3700 m), atmospheric pressure and partial pressure of oxygen (PO₂) decrease significantly, leading to hypoxemia. The body's immediate response to hypoxia is cerebral vasodilation — a protective mechanism to increase cerebral blood flow and oxygen delivery to the brain. This vasodilation increases intracranial pressure and cerebral edema, which directly explains the classic triad of acute mountain sickness (AMS): headache, nausea, and dizziness. The dyspnea occurs due to hypoxemia-driven hyperventilation as the respiratory center attempts to increase oxygen uptake. According to Guyton's Physiology, hypoxia is a potent cerebral vasodilator (unlike systemic circulation where hypoxia causes vasoconstriction). The headache is the hallmark symptom of AMS and results from increased intracranial pressure secondary to vasodilation and fluid retention. This pathophysiology is well-documented in Harrison's and forms the basis for AMS prevention and management in Indian high-altitude regions (Himalayas, Ladakh). The vasodilation mechanism is why acetazolamide (a carbonic anhydrase inhibitor) works — it causes metabolic acidosis, which paradoxically reduces cerebral vasodilation and prevents AMS.
Why the other options are wrong
B. Metabolic acidosis causing edema — While metabolic acidosis does occur at altitude (due to anaerobic metabolism and acetazolamide use), it is NOT the primary cause of AMS symptoms. Metabolic acidosis is actually protective — it reduces cerebral vasodilation and is therapeutically exploited in AMS prevention. The edema in AMS is cerebral (from vasodilation + hypoxia-induced fluid retention), not systemic metabolic acidosis-induced edema. This option confuses the mechanism with the treatment. C. High PO₂ causing vasoconstriction — This is factually inverted — at 3700 m, PO₂ is low, not high. High PO₂ would cause vasoconstriction, but that is not the scenario here. This option tests whether students confuse altitude physiology with hyperoxia. The question explicitly describes high-altitude exposure, where hypoxemia (low PO₂) is the defining feature, not hyperoxia. D. Hypoxia causing vasoconstriction — This is the classic NBE trap: students often confuse cerebral and systemic vascular responses to hypoxia. While hypoxia causes systemic vasoconstriction (pulmonary hypertension, peripheral vasoconstriction), it causes cerebral vasodilation — the opposite. This option exploits the misconception that hypoxia uniformly causes vasoconstriction everywhere, ignoring organ-specific autoregulation.
High-Yield Facts
- Acute Mountain Sickness (AMS) at altitudes >2500 m is caused by hypoxia-induced cerebral vasodilation, not vasoconstriction.
- Cerebral vasodilation in hypoxia increases intracranial pressure and cerebral edema, producing headache, nausea, and dizziness — the classic AMS triad.
- Hypoxia causes opposite effects in cerebral vs. systemic circulation: cerebral vasodilation (protective) vs. systemic vasoconstriction (pulmonary hypertension).
- Acetazolamide prevents AMS by inducing metabolic acidosis, which paradoxically reduces cerebral vasodilation and improves oxygenation.
- PO₂ at 3700 m is approximately 60–70 mmHg (vs. 100 mmHg at sea level), triggering hypoxic ventilatory response and cerebral autoregulation.
Mnemonics
AMS = Altitude + Vasodilation + Symptoms Altitude → Vasodilation (cerebral) → Symptoms (Headache, Nausea, Dizziness). Remember: hypoxia dilates cerebral vessels to increase blood flow, but this raises intracranial pressure. Hypoxia's Opposite Effects: BRAIN vs BODY BRAIN: hypoxia → vasodilation (↑ blood flow). BODY: hypoxia → vasoconstriction (↓ peripheral perfusion, ↑ pulmonary pressure). Use this to avoid confusing cerebral and systemic responses.
NBE Trap
NBE pairs hypoxia with vasoconstriction (Option D) to exploit the common misconception that hypoxia uniformly causes vasoconstriction everywhere. Students who memorize "hypoxia → vasoconstriction" without distinguishing organ-specific responses fall into this trap. The correct answer requires knowing that cerebral circulation uniquely dilates in response to hypoxia, unlike systemic vessels.
Clinical Pearl
In Indian high-altitude regions (Himalayas, Ladakh), trekkers and military personnel commonly develop AMS within 6–12 hours of ascent. The headache is often the first warning sign and should prompt immediate descent or acetazolamide initiation. Understanding that vasodilation (not vasoconstriction) drives symptoms helps clinicians recognize that oxygen supplementation and descent are the definitive treatments, while acetazolamide works by inducing acidosis to reduce vasodilation.
_Reference: Guyton & Hall Physiology Ch. 38 (Cerebral Blood Flow); Harrison's Principles of Internal Medicine Ch. 476 (High-Altitude Medicine); KD Tripathi Pharmacology Ch. 12 (Acetazolamide and AMS)_